Vanguard Group’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.4M Sell
6,556,243
-131,557
-2% -$1.07M ﹤0.01% 2086
2025
Q1
$52.5M Buy
6,687,800
+1,298,584
+24% +$10.2M ﹤0.01% 2079
2024
Q4
$80.2M Sell
5,389,216
-79,539
-1% -$1.18M ﹤0.01% 1954
2024
Q3
$83.6M Buy
5,468,755
+211,429
+4% +$3.23M ﹤0.01% 1958
2024
Q2
$80.1M Buy
5,257,326
+466,082
+10% +$7.1M ﹤0.01% 1942
2024
Q1
$90.5M Buy
4,791,244
+110,528
+2% +$2.09M ﹤0.01% 1916
2023
Q4
$89.4M Buy
4,680,716
+186,898
+4% +$3.57M ﹤0.01% 1923
2023
Q3
$80.7M Buy
4,493,818
+61,040
+1% +$1.1M ﹤0.01% 1919
2023
Q2
$90M Buy
4,432,778
+9,119
+0.2% +$185K ﹤0.01% 1912
2023
Q1
$80.7M Buy
4,423,659
+50,482
+1% +$921K ﹤0.01% 1925
2022
Q4
$90.4M Sell
4,373,177
-84,007
-2% -$1.74M ﹤0.01% 1857
2022
Q3
$117M Buy
4,457,184
+173,854
+4% +$4.55M ﹤0.01% 1692
2022
Q2
$109M Buy
4,283,330
+771,216
+22% +$19.5M ﹤0.01% 1765
2022
Q1
$111M Buy
3,512,114
+85,778
+3% +$2.71M ﹤0.01% 1882
2021
Q4
$139M Buy
3,426,336
+959,857
+39% +$38.8M ﹤0.01% 1800
2021
Q3
$86M Buy
2,466,479
+37
+0% +$1.29K ﹤0.01% 2067
2021
Q2
$67.7M Sell
2,466,442
-58,407
-2% -$1.6M ﹤0.01% 2208
2021
Q1
$70.9M Buy
2,524,849
+177,225
+8% +$4.98M ﹤0.01% 2124
2020
Q4
$60.9M Buy
2,347,624
+141,684
+6% +$3.68M ﹤0.01% 2102
2020
Q3
$37.8M Buy
2,205,940
+12,820
+0.6% +$220K ﹤0.01% 2151
2020
Q2
$54.3M Buy
2,193,120
+668,026
+44% +$16.5M ﹤0.01% 1973
2020
Q1
$21.2M Buy
1,525,094
+127,844
+9% +$1.77M ﹤0.01% 2254
2019
Q4
$14.1M Buy
1,397,250
+1,988
+0.1% +$20.1K ﹤0.01% 2692
2019
Q3
$12.7M Buy
1,395,262
+302,841
+28% +$2.76M ﹤0.01% 2704
2019
Q2
$8.69M Sell
1,092,421
-69,525
-6% -$553K ﹤0.01% 2938
2019
Q1
$14.5M Buy
1,161,946
+47,744
+4% +$596K ﹤0.01% 2646
2018
Q4
$12M Buy
1,114,202
+661,793
+146% +$7.13M ﹤0.01% 2678
2018
Q3
$6.31M Buy
452,409
+12,511
+3% +$174K ﹤0.01% 3146
2018
Q2
$5.39M Buy
439,898
+379,898
+633% +$4.65M ﹤0.01% 3194
2018
Q1
$927K Buy
+60,000
New +$927K ﹤0.01% 3659